Insider · CIK 0001205465

HULL CARL

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001205465

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-11-11	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.P Purchase	Director, See Remarks	PPurchase	+175K sh	$5.64	+$987K	175,000
2024-03-15	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.F Tax Payment	Director, See Remarks	FTax Payment	−17.6K sh	$7.70	−$135K	267,072
2024-02-15	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.F Tax Payment	Director, See Remarks	FTax Payment	−10.7K sh	$5.48	−$58.8K	284,632
2024-01-16	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.A Award	Director, See Remarks	AAward	+75.8K sh	—	—	295,361
2023-03-15	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. · Employee Stock Options (Right to Buy)A Award	Director, See Remarks	AAward	+270K sh	—	—	270,109
2023-03-15	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.A Award	Director, See Remarks	AAward	+148K sh	—	—	219,519
2023-02-15	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.F Tax Payment	Director, See Remarks	FTax Payment	−9,719 sh	$15.23	−$148K	71,881
2022-05-27	Ortho Clinical Diagnostics Holdings plcD Disposition to Issuer	Director	DDisposition to Issuer	−41.2K sh	—	—	0
2022-05-27	Ortho Clinical Diagnostics Holdings plcD Disposition to Issuer	Director	DDisposition to Issuer	−21K sh	—	—	0
2022-01-25	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.A Award	Director, See Remarks	AAward	+81.6K sh	—	—	81,600
2022-01-25	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. · Employee Stock Options (Right to Buy)A Award	Director, See Remarks	AAward	+151K sh	—	—	151,200
2021-05-03	Ortho Clinical Diagnostics Holdings plcA Award	Director	AAward	+2,600 sh	—	—	21,011
2020-11-25	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.P Purchase	Director, See Remarks	PPurchase	+35K sh	$26.94	+$943K	35,000
2020-11-19	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. · Employee Stock Options (Right to Buy)A Award	Director, See Remarks	AAward	+60K sh	—	—	60,000
2013-02-01	HOLXHOLOGIC INCF Tax Payment	SVP and GM of Diagnostics	FTax Payment	−81.7K sh	$23.72	−$1.94M	61,674
2012-11-14	HOLXHOLOGIC INCA Award	SVP and GM of Diagnostics	AAward	+10.1K sh	—	—	143,403
2012-11-14	HOLXHOLOGIC INC · Non-qualified Stock Option (Right to Buy)A Award	SVP and GM of Diagnostics	AAward	+28.1K sh	$19.86	+$557K	28,050
2012-08-01	GEN PROBE INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−62.2K sh	$35.33	−$2.2M	0
2012-08-01	GEN PROBE INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−35K sh	$21.93	−$768K	0
2012-08-01	GEN PROBE INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−37.5K sh	$22.60	−$848K	0
2012-08-01	GEN PROBE INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−19.5K sh	$39.03	−$760K	0
2012-08-01	HOLXHOLOGIC INCA Award	SVP and GM of Diagnostics	AAward	+133K sh	—	—	133,333
2012-08-01	GEN PROBE INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−113K sh	$18.95	−$2.13M	0
2012-08-01	GEN PROBE INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−110K sh	—	—	0
2012-08-01	GEN PROBE INCPerformance Stock RightsD Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−10K sh	—	—	0
2012-08-01	GEN PROBE INCPerformance Stock RightsD Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−40K sh	—	—	0
2012-08-01	GEN PROBE INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−105K sh	$40.09	−$4.21M	0
2012-08-01	GEN PROBE INCD Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−47K sh	$82.75	−$3.89M	0
2012-04-17	GEN PROBE INCS Sale	Director, Chairman and CEO	SSale	−5,883 sh	$66.23	−$390K	48,167
2012-04-17	GEN PROBE INCM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+7,083 sh	$47.42	+$336K	54,050
2012-04-17	GEN PROBE INCS Sale	Director, Chairman and CEO	SSale	−1,200 sh	$66.65	−$80K	46,967
2012-04-17	GEN PROBE INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−7,083 sh	—	—	62,188
2012-03-16	GEN PROBE INCS Sale	Director, Chairman and CEO	SSale	−12.1K sh	$66.56	−$804K	46,967
2012-03-16	GEN PROBE INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−6,354 sh	—	—	19,480
2012-03-16	GEN PROBE INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−5,729 sh	—	—	69,271
2012-03-16	GEN PROBE INCM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+6,354 sh	$43.72	+$278K	53,321
2012-03-16	GEN PROBE INCM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+5,729 sh	$47.42	+$272K	59,050
2012-02-16	GEN PROBE INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−12.1K sh	—	—	25,834
2012-02-16	GEN PROBE INCS Sale	Director, Chairman and CEO	SSale	−12.1K sh	$69.14	−$835K	46,967
2012-02-16	GEN PROBE INCM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+12.1K sh	$43.72	+$528K	59,050
2012-02-10	GEN PROBE INCF Tax Payment	Director, Chairman and CEO	FTax Payment	−719 sh	$69.22	−$49.8K	46,967
2012-02-10	GEN PROBE INCPerformance Stock RightsM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−5,948 sh	—	—	10,001
2012-02-10	GEN PROBE INCPerformance Stock RightsA Award	Director, Chairman and CEO	AAward	+40K sh	—	—	40,000
2012-02-10	GEN PROBE INCStock Options (Right to Buy)A Award	Director, Chairman and CEO	AAward	+110K sh	—	—	110,000
2012-02-10	GEN PROBE INCM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+5,948 sh	—	—	49,652
2012-02-10	GEN PROBE INCF Tax Payment	Director, Chairman and CEO	FTax Payment	−1,966 sh	$69.22	−$136K	47,686
2012-02-10	GEN PROBE INCPerformance Stock RightsA Award	Director, Chairman and CEO	AAward	+949 sh	—	—	15,949
2012-01-17	GEN PROBE INCS Sale	Director, Chairman and CEO	SSale	−17.1K sh	$60.86	−$1.04M	43,704
2012-01-17	GEN PROBE INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−17.1K sh	—	—	37,917
2012-01-17	GEN PROBE INCM Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+17.1K sh	$43.72	+$747K	60,787

Recent filings

Accepted (ET)
Nov 124
HULL CARL0001823239-24-000113
SEC(opens sec.gov)
Mar 184
HULL CARL0001823239-24-000034
SEC(opens sec.gov)
Feb 204
HULL CARL0001823239-24-000023
SEC(opens sec.gov)
Jan 184
HULL CARL0001823239-24-000008
SEC(opens sec.gov)
Mar 174
HULL CARL0001823239-23-000026
SEC(opens sec.gov)
Feb 174
HULL CARL0001823239-23-000008
SEC(opens sec.gov)
Jun 14
HULL CARL0001209191-22-033124
SEC(opens sec.gov)
Jan 274
HULL CARL0000899243-22-003415
SEC(opens sec.gov)
May 54
HULL CARL0001209191-21-030376
SEC(opens sec.gov)
Nov 304
HULL CARL0000899243-20-032306
SEC(opens sec.gov)
Nov 234
HULL CARL0000899243-20-031948
SEC(opens sec.gov)
Feb 54
HOLOGIC INC0001127602-13-004223
SEC(opens sec.gov)
Nov 154
HOLOGIC INC0001127602-12-030903
SEC(opens sec.gov)
Aug 24
GEN PROBE INC0001179110-12-012298
SEC(opens sec.gov)

Companies

Address

GEN-PROBE INCORPORATED 10210 GENETIC CENTER DRIVE

SAN DIEGO, CA, 92121